Name:João Seabra

New position:President and Head of Siemens Healthineers Americas

Previous position:Head of Enterprise Services at Siemens Healthineers

Siemens Healthineers announced on Thursday that it has appointed João Seabra as President and Head of the Americas. This personnel change is part of the company's leadership transition plan initiated in May.

Seabra joined Siemens Healthineers in 2001. Between 2015 and 2018, he was responsible for the company's operations in Western Europe and West Africa. Since 2018, Seabra has served as Head of Enterprise Services, under whose leadership the business continued to expand and revenue quadrupled, earning him a promotion to lead Siemens Healthineers' largest regional market.

Siemens Healthineers Chief Human Resources Officer Darleen Caron said in a statement that under Seabra's leadership, the company has established "broader and more impactful value partnerships with key customers."

Seabra is currently based in Portugal and will relocate to the United States for his new role. Effective October 1, Seabra will succeed John Kowal. Kowal previously served as President of the Americas for Siemens Healthineers' Varian division, assuming the role in April 2025 to fill the vacancy left by David Pacitti's departure—the latter having moved on to lead Avanos.

In the announcement of Seabra's appointment, Siemens Healthineers expressed gratitude to Kowal for his "years of successful service." Kowal said in a LinkedIn post that he will step down and, in the near term, devote time to "personal passions."

Seabra's appointment is the latest in a series of leadership changes at the company. In May, Siemens Healthineers disclosed a "comprehensive generational transition" within its leadership team. The changes involve new heads for Medical Imaging, Advanced Therapies, and the Europe, Middle East, and Africa region, along with the appointment of a new Chief Technology Officer.

The May leadership changes coincided with Siemens Healthineers' plan to spin off its diagnostics business. In the third-quarter results released on Friday, the diagnostics business underperformed again. During a conference call with analysts, CEO Bernhard Montag attributed part of the sales decline to structural changes in the Chinese market.

CFO Jochen Schmitz said on the call that Siemens Healthineers expects diagnostics sales to continue declining in the fourth quarter. Based on this forecast, the company lowered both ends of its full-year revenue growth guidance by one percentage point, with expected growth now between 3.5% and 4%.